» Articles » PMID: 11131147

Alpha1-antichymotrypsin and Kallistatin Hydrolysis by Human Cathepsin D

Overview
Journal J Protein Chem
Specialties Biochemistry
Chemistry
Date 2000 Dec 29
PMID 11131147
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

In the present paper, we demonstrate that alpha1-antichymotrypsin, a serpin with high inhibitory specificity toward cathepsin G, and kallistatin, a human serpin with high specificity toward tissue kallikrein, are digested by cathepsin D. Alpha1-Antichymotrypsin was hydrolyzed essentially in the reactive center loop at L-S, A-L, or L-V bonds; kallistatin was split into small fragments, but we detected the cleavage at F-F and F-S bonds in its reactive center loop in the first 15 min of digestion. In contrast to alpha1-antichymotrypsin, kallistatin is irreversibly inactivated at pH 4.0. Synthetic internally quenched fluorescent peptides containing sequences similar to the reactive center loops of these serpins were hydrolyzed by cathepsin D. The peptides derived from kallistatin were hydrolyzed more efficiently, and particularly relevant was the high susceptibility of the substrates Abz-AIKFFSAQTNRHILRFNRQ-EDDnp (Km = 0.08 microM, kcat = 2.4 s(-1)) and Abz-AIKFFSAQTNRQ-EDDnp (Km = 0.8 microM, kcat = 17.8 s(-1)), which were hydrolyzed at the F-F bond. Therefore, besides the description of a new class of very efficient internally quenched substrates for cathepsin D, we give evidence for the downregulation role of this proteinase on alpha1-antichymotrypsin and kallistatin. The acidification of extracellular milieu by tumor cells can result in activation of cathepsin D; as a consequence, kinins can be released, improving blood supply and leaving more cathepsin G available for the degradation of extracellular matrix.

Citing Articles

Adamantinomatous craniopharyngioma: advances in proteomic research.

Desiderio C, Rossetti D, Castagnola M, Massimi L, Tamburrini G Childs Nerv Syst. 2020; 37(3):789-797.

PMID: 32617710 DOI: 10.1007/s00381-020-04750-z.


Investigating the Protein Signature of Adamantinomatous Craniopharyngioma Pediatric Brain Tumor Tissue: Towards the Comprehension of Its Aggressive Behavior.

Martelli C, Serra R, Inserra I, Rossetti D, Iavarone F, Vincenzoni F Dis Markers. 2019; 2019:3609789.

PMID: 31191748 PMC: 6525946. DOI: 10.1155/2019/3609789.


Nanomedical strategy to prolong survival period, heighten cure rate, and lower systemic toxicity of S180 mice treated with MTX/MIT.

Song N, Zhao M, Wang Y, Hu X, Wu J, Jiang X Drug Des Devel Ther. 2016; 10:2701-11.

PMID: 27621591 PMC: 5012610. DOI: 10.2147/DDDT.S113804.


Proteolytic characteristics of cathepsin D related to the recognition and cleavage of its target proteins.

Sun H, Lou X, Shan Q, Zhang J, Zhu X, Zhang J PLoS One. 2013; 8(6):e65733.

PMID: 23840360 PMC: 3688724. DOI: 10.1371/journal.pone.0065733.


Apolipoprotein A1 and C-terminal fragment of α-1 antichymotrypsin are candidate plasma biomarkers associated with acute renal allograft rejection.

Ziegler M, Chen T, Leblanc J, Wei X, Gjertson D, Li K Transplantation. 2011; 92(4):388-95.

PMID: 21730889 PMC: 3878300. DOI: 10.1097/TP.0b013e318225db6a.


References
1.
Bazel S, Alhadeff J . Characterization of purified cathepsin D from malignant human breast tissue. Int J Oncol. 1999; 14(2):315-9. View

2.
Zhao Q, Piot J . Neokyotorphin formation and quantitative evolution following human hemoglobin hydrolysis with cathepsin D. Peptides. 1998; 19(4):759-66. DOI: 10.1016/s0196-9781(98)00002-3. View

3.
Diment S, Stahl P . Macrophage endosomes contain proteases which degrade endocytosed protein ligands. J Biol Chem. 1985; 260(28):15311-7. View

4.
Wu J, Akaike T, Maeda H . Modulation of enhanced vascular permeability in tumors by a bradykinin antagonist, a cyclooxygenase inhibitor, and a nitric oxide scavenger. Cancer Res. 1998; 58(1):159-65. View

5.
Schechter I, Berger A . On the active site of proteases. 3. Mapping the active site of papain; specific peptide inhibitors of papain. Biochem Biophys Res Commun. 1968; 32(5):898-902. DOI: 10.1016/0006-291x(68)90326-4. View